Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)

China flag China · Delayed Price · Currency is CNY
6.84
+0.08 (1.18%)
At close: Feb 4, 2026
15.54%
Market Cap3.44B +16.9%
Revenue (ttm)1.05B +8.9%
Net Income172.02M -23.9%
EPS0.34 -23.9%
Shares Out503.20M
PE Ratio20.01
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,942,800
Average Volume9,010,963
Open6.76
Previous Close6.76
Day's Range6.72 - 6.85
52-Week Range5.21 - 7.36
Beta0.26
RSI53.03
Earnings DateApr 28, 2026

About SHE:002412

Hunan Hansen Pharmaceutical Co., Ltd. engages in the production and sale of traditional Chinese preparations in China and internationally. The company offers digestive system medicines; cardiovascular and cerebrovascular medicines; kidney-tonifying and urine-reducing medicines; trauma medicines; diagnostic medicines, etc. It provides medicines in injection, mixture, tablet, capsule, granule, syrup, decoction, tincture, and pill forms. Hunan Hansen Pharmaceutical Co., Ltd. is based in Yiyang, China. [Read more]

Sector Healthcare
Founded 1998
Employees 1,675
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002412
Full Company Profile

Financial Performance

In 2024, SHE:002412's revenue was 1.00 billion, an increase of 5.12% compared to the previous year's 955.53 million. Earnings were 220.24 million, an increase of 7.43%.

Financial Statements